The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors

Human Gene Therapy

Volumn 22, Issue 6, 2011, Pages 761-774

  Emery, David W ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Box 358056 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; PROTEIN CHS4; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS VECTOR;

ARTICLE; CHROMATIN; GENE EXPRESSION; GENE INTERACTION; GENE SILENCING; GENE TRANSFER; GENOTOXICITY; INSULATOR ELEMENT; MALIGNANT TRANSFORMATION; NONHUMAN; TRANSGENE; VECTOR CONTROL;

ANIMALS; CHROMATIN; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INSULATOR ELEMENTS; MICE; RETROVIRIDAE; TRANSGENES;

EID: 79955852358     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2010.233     Document Type: Article

References (108)

1. Abujamra, A.L., Spanjaard, R.A., Akinsheye, I., et al. (2006). Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism. Virology 345, 390-403. (Pubitemid 43189898)
2. Akagi, K., Suzuki, T., Stephens, R.M., et al. (2004). RTCGD: ret-roviral tagged cancer gene database. Nucleic Acids Res. 32, D523-527.
3. Aker, M., Bomsztyk, K., and Emery, D.W. (2010). Poly (ADP-ribose) polymerase-1 (PARP-1) contributes to the barrier activity function of a vertebrate chromatin insulator. J. Biol. Chem. 285, 37589-37597.
4. Aker, M., Tubb, J., Groth, A.C., et al. (2007). Extended core sequences from the cHS4 insulator are necessary for protecting retroviral vectors from silencing position effects. Hum. Gene Ther. 18, 333-343. (Pubitemid 46709345)
5. Aker, M., Tubb, J., Miller, D.G., et al. (2006). Integration bias of gammaretrovirus vectors following transduction and growth of primary mouse hematopoietic progenitor cells with and without selection. Mol. Ther. 14, 226-235. (Pubitemid 43942346)
6. Artelt, P., Grannemann, R., Stocking, C., et al. (1991). The pro-karyotic neomycin-resistance-encoding gene acts as a tran-scriptional silencer in eukaryotic cells. Gene 99, 249-254.
7. Arumugam, P.I., Higashimoto, T., Urbinati, F., et al. (2009b). Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control region. Mol. Ther. 17, 1929-1937.
8. Arumugam, P.I., Scholes, J., Perelman, N., et al. (2007). Improved human beta-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator element. Mol. Ther. 15, 1863-1871. (Pubitemid 47434195)
9. 0 region of the chicken hypersensitive site-4 insulator has properties similar to its core and is required for full insulator activity. PLoS ONE 4, e6995.
10. Bank, A., Dorazio, R., and Leboulch, P. (2005). A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia. Ann. N. Y. Acad. Sci. 1054, 308-316. (Pubitemid 43031038)
11. Baum, C., Kustikova, O., Modlich, U., et al. (2006a). Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum. Gene Ther. 17, 252-263.
12. Baum, C., Schambach, A., Bohne, J., and Galla, M. (2006b). Retrovirus vectors: toward the plentivirus? Mol. Ther. 13, 1050-1063. (Pubitemid 43779189)
13. Bell, A.C., West, A.G., and Felsenfeld, G. (1999). The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell 98, 387-396. (Pubitemid 29380573)
14. Berry, C., Hannenhalli, S., Leipzig, J., and Bushman, F.D. (2006). Selection of target sites for mobile DNA elements in the human genome. PLoS Comput. Biol. 2, e157.
15. Bos, T.J., de Bruyne, E., van Lint, S., et al. (2010). Large double copy vectors are functional but show size-dependent decline in transduction efficiency. J. Biotechnol. 150, 37-40.
16. Cavazzana-Calvo, M., Payen, E., Negre, O., et al. (2010). Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature 467, 318-322.
17. Challita, P.M., Skelton, D., El-Khoueiry, A., et al. (1995). Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J. Virol. 69, 748-755.
18. Chang, A.H., and Sadelain, M. (2007). The genetic engineering of hematopoietic stem cells: the rise of lentiviral vectors, the conundrum of the LTR, and the promise of lineage-restricted vectors. Mol. Ther. 15, 445-456.
19. Chang, L.J., Liu, X., and He, J. (2005). Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1. Gene Ther. 12, 1133-1144. (Pubitemid 41030619)
20. Chung, J.H., Bell, A.C., and Felsenfeld, G. (1997). Characterization of the chicken beta-globin insulator. Proc. Natl. Acad. Sci. USA 94, 575-580.
21. 0 element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effects in Drosophila. Cell 74, 505-514. (Pubitemid 23244616)
22. D'Apolito, D., Baiamonte, E., Bagliesi, M., et al. (2009). The sea urchin sns5 insulator protects retroviral vectors from chromosomal position effects by maintaining active chromatin structure. Mol. Ther. 17, 1434-1441.
23. Desprat, R., and Bouhassira, E.E. (2009). Gene specificity of suppression of transgene-mediated insertional transcriptional activation by the chicken HS4 insulator. PLoS 4, e5956.
24. Dickson, J., Gowher, H., Strogantsev, R., et al. (2010). VEZF1 elements mediate protection from DNA methylation. PLoS Genet. 6, e1000804.
25. Di Simone, P., Di Leonardo, A., Costanzo, G., et al. (2001). The sea urchin sns insulator blocks CMV enhancer following integration in human cells. Biochem. Biophys. Res. Commun. 284, 987-992. (Pubitemid 32924746)
26. Ellis, J. (2005). Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum. Gene Ther. 16, 1241-1246. (Pubitemid 41611651)
27. Emery, D.W., Aker, M., and Stamatoyannopoulos, G. (2003). Chromatin insulators and position effects. In Gene Transfer and Expression in Mammalian Cells. Makrides, S.C., ed. (EIC Laboratories, Inc., Norwood, MA.) pp. 381-395. (Pubitemid 137641006)
28. Emery, D.W., Chen, H., Li, Q., and Stamatoyannopoulos, G. (1998). Development of a condensed locus control region cassette and testing in retrovirus vectors for A gamma-globin. Blood Cells Mol. Dis. 24, 322-339. (Pubitemid 28524833)
29. Emery, D.W., Tubb, J., Nishino, Y., et al. (2005). Selection with a regulated cell growth switch increases the likelihood of expression for a linked gamma-globin gene. Blood Cells Mol. Dis. 34, 235-247. (Pubitemid 40693561)
30. Emery, D.W., Yannaki, E., Bell, A., et al. (1999). Core elements from Drosophila gypsy and chicken beta-globin HS4 do not insulate retrovirus vectors from position effects. Blood 94 (suppl. 1), 177a.
31. Emery, D.W., Yannaki, E., Tubb, J., and Stamatoyannopoulos, G. (2000). A chromatin insulator protects retrovirus vectors from position effects. Proc. Natl. Acad. Sci. U. S. A. 97, 9150-9155. (Pubitemid 30626689)
32. Emery, D.W., Yannaki, E., Tubb, J., et al. (2002). Development of virus vectors for gene therapy of b chain hemoglobinopathies: flanking with a chromatin insulator reduces g-globin gene silencing in vivo. Blood 100, 2012-2021.
33. Evans-Galea, M.V., Wielgosz, M.M., Hanawa, H., et al. (2007). Suppression of clonal dominance in cultured human lymphoid cells by addition of the cHS4 insulator to a lentiviral vector. Mol. Ther. 15, 801-809. (Pubitemid 46432001)
34. Farrar, D., Rai, S., Chernukhin, I., et al. (2010). Mutational analysis of the poly(ADP-ribosyl)ation sites of the transcription factor CTCF provides an insight into the mechanism of its regulation by poly(ADP-ribosyl)ation. Mol. Cell. Biol. 30, 1199-1216.
35. Gallagher, P.G., Steiner, L.A., Liem, R.I., et al. (2010). Mutation of a barrier insulator in the human ankyrin-1 gene is associated with hereditary spherocytosis. J. Clin. Invest. 120, 4453-3365.
36. Gao, Q., Sun, M., Wang, X, and Geller, A.I. (2007). Isolation of an enhancer from the rat tyrosine hydroxylase promoter that supports long-term, neuronal-specific expression from a Neurofilament promoter, in a helper virus-free HSV-1 vector system. Brain Res. 1130, 1-16. (Pubitemid 46053873)
37. Gaszner, M., and Felsenfeld, G. (2006). Insulators: exploiting transcriptional and epigenetic mechanisms. Nat. Rev. Genet. 7, 703-713. (Pubitemid 44260006)
38. Groth, A.C., and Emery, D.W. (2010). A functional screen for regulatory elements that improve retroviral vector gene expression. Blood Cells Mol. Dis. 45, 343-350.
39. Guelen, L., Pagie, L., Brasset, E., et al. (2008). Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature 453, 948-951. (Pubitemid 351832561)
40. Hacein-Bey-Abina, S., Le Deist, F., Carlier, F., et al. (2002). Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346, 1185-1193. (Pubitemid 34984579)
41. Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., et al. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419. (Pubitemid 37296260)
42. Hanawa, H., Yamamoto, M., Zhao, H., et al. (2009). Optimized lentiviral vector design improves titer and transgene expression of vectors containing the chicken beta-globin locus HS4 insulator element. Mol. Ther. 17, 667-674.
43. Hantzopoulos, P.A., Sullenger, B.A., Ungers, G., and Gilboa, E. (1989). Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc. Natl. Acad. Sci. U.S.A. 86, 3519-3523.
44. Hargrove, P.W., Kepes, S., Hanawa, H., et al. (2008). Globin lentiviral vector insertions can perturb the expression of endogenous genes in beta-thalassemic hematopoietic cells. Mol. Ther. 16, 525-533. (Pubitemid 351314992)
45. Higashimoto, T., Urbinati, F., Perumbeti, A., et al. (2007). The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors. Gene Ther. 14, 1298-1304. (Pubitemid 47299954)
46. Hino, S., Fan, J., Taguwa, S., et al. (2004). Sea urchin insulator protects lentiviral vector from silencing by maintaining active chromatin structure. Gene Ther. 11, 819-828. (Pubitemid 38714585)
47. Hou, C., Dale, R. and Dean, A. (2010). Cell type specificity of chromatin organization mediated by CTCF and cohesin. Proc. Natl. Acad. Sci. U. S. A. 107, 3651-3656.
48. Jakobsson, J., Rosenqvist, N., Thompson, L., et al. (2004). Dynamics of transgene expression in a neural stem cell line transduced with lentiviral vectors incorporating the cHS4 insulator. Exp. Cell Res. 298, 611-623. (Pubitemid 38950876)
49. Jin, C., Zhang, C., Wei, G., et al. (2009). H3.3/H2A.Z double variant-containing nucleosides are 'nucleosome-free regions' of active promoters and other regulatory regions. Nat. Genet. 41, 941-945.
50. Kohn, D.B., Sadelain, M., Dunbar, C., et al. (2003). American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Mol. Ther. 8, 180-187. (Pubitemid 37062828)
51. Kraus, W.L. (2008). Transcriptional control by PARP-1: chro-matin modulation, enhancer-binding, coregulation, and insulation. Curr. Opin. Cell Biol. 20, 294-302.
52. Li, C.L., and Emery, D.W. (2008). The cHS4 chromatin insulator reduces gammaretroviral vector silencing by epigenetic modifications of integrated provirus. Gene Ther. 15, 49-53. (Pubitemid 350269432)
53. Li, C.L., Xiong, D., Stamatoyannopoulos, G., and Emery, D.W. (2009). Genomic and functional assays demonstrate reduced gammaretroviral vector genotoxicity associated with use of the cHS4 chromatin insulator. Mol. Ther. 17, 716-724.
54. Ling, J.Q., Li, T., Hu, J.F., et al. (2006). CTCF mediates inter-chromosomal colocalization between Igf2/H19 and Wsb1/ Nf1. Science 312, 269-272.
55. Litt, M.D., Simpson, M., Gaszner, M., et al. (2001). Correlation between histone lysine methylation and developmental changes at the chicken beta-globin locus. Science 293, 2453-2455. (Pubitemid 32917326)
56. Ma, Y., Ramezani, A., Lewis, R., et al. (2003). High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 21, 111-117. (Pubitemid 36120372)
57. Makrides, S.C., ed. (2003). Gene Transfer and Expression in Mammalian Cells. (EIC Laboratories, Inc., Norwood, MA).
58. Martin-Duque, P., Jezzard, S., Kaftansis, L., and Vassaux, G. (2004). Direct comparison of the insulating properties of two genetic elements in an adenoviral vector containing two different expression cassettes. Hum. Gene Ther. 15, 995-1002. (Pubitemid 39372576)
59. May, C., Rivella, S., Callegari, J., et al. (2000). Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing len-tivirus-encoded human beta-globin. Nature 406, 82-86. (Pubitemid 30460215)
60. Mitra, K., Su, M., and Lenz, J. (2007). Multiple tandem insulators may reduce retroviral insertional activation of oncogenes and lymphomagenesis. Mol. Ther. 15 (suppl. 1), S28.
61. Modin, C., Pedersen, F.S., and Duch, M. (2000). Lack of shielding of primer binding site silencer-mediated repression of an internal promoter in a retrovirus vector by the putative insulators scs, BEAD-1, and HS4. J. Virol. 74, 11697-11707. (Pubitemid 32222319)
62. Modlich, U., Bohne, J., Schmidt, M., et al. (2006). Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood 108, 2545-2553.
63. Mok, H.P., Javed, S., and Lever, A. (2007). Stable gene expression occurs from a minority of integrated HIV-1-based vectors: transcriptional silencing is present in the majority. Gene Ther. 14, 741-751. (Pubitemid 46585655)
64. Montini, E., Cesana, D., Schmidt, M., et al. (2006). Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat. Biotech. 24, 687-696. (Pubitemid 43882120)
65. Montini, E., Cesana, D., Schmidt, M., et al. (2009). The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J. Clin. Invest. 119, 964-975.
66. Mutskov, V.J., Farrell, C.M., Wade, P.A., et al. (2002). The barrier function of an insulator couples high histone acetylation levels with specific protection of promoter DNA from methylation. Genes Dev. 16, 1540-1554. (Pubitemid 34686335)
67. Nienhuis, A.W., Dunbar, C.E., and Sorrentino, B.P. (2006). Genotoxicity of retroviral integration in hematopoietic cells. Mol. Ther. 13, 1031-1049. (Pubitemid 43779188)
68. Nishino, T., Tubb, J., and Emery, D.W. (2006). Partial correction of murine beta-thalassemia with a gammaretrovirus vector for human g-globin. Blood Cells Mol. Dis. 37, 1-7. (Pubitemid 44062363)
69. Osti, D., Marras, E., Ceriani, I., et al. (2006). Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes. J. Virol. Methods 136, 93-101. (Pubitemid 44051581)
70. Ott, M.G., Schmidt, M., Schwarzwaelder, K., et al. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med. 12, 401-409.
71. Pathak, V.K., and Temin, H.M. (1990). Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc. Natl. Acad. Sci. U. S. A. 87, 6024-6028.
72. Persons, D.A., Hargrove, P.W., Allay, E.R., et al. (2003). The degree of phenotypic correction of murine beta-thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number. Blood 101, 2175-2183. (Pubitemid 36302055)
73. Phillips, J.E., and Corces, V.G. (2009). CTCF: Master weaver of the genome. Cell 137, 1194-1211.
74. Pluta, K., Luce, M.J., Bao, L., et al. (2005). Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters. J. Gene Med. 7, 803-807.
75. Puthenveetil, G., Scholes, J., Carbonell, D., et al. (2004). Successful correction of the human beta-thalassemia major phe-notype using a lentiviral vector. Blood 104, 3445-3453. (Pubitemid 39564412)
76. Raab, J.R., and Kamakaka, R.T. (2010). Insulators and promoters: closer than we think. Nat. Rev. Genet. 11, 439-446.
77. Ramezani, A., Hawley, T.S., and Hawley, R.G. (2003). Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator. Blood 101, 4717-4724. (Pubitemid 36857727)
78. Ramezani, A., Hawley, T.S., and Hawley, R.G. (2006). Stable gammaretroviral vector expression during embryonic stem cell-derived in vitro hematopoietic development. Mol. Ther. 14, 245-254. (Pubitemid 43942353)
79. Ramezani, A., Hawley, T.S., and Hawley, R.G. (2008). Combinatorial incorporation of enhancer-blocking components of the chicken beta-globin 5'HS4 and human T-cell receptor alpha/ delta BEAD-1 insulators in self-inactivating retroviral vectors reduces their genotoxic potential. Stem Cells 26, 3257-3266.
80. Ramunas, J., Montgomery, H.J., Kelly, L., et al. (2007). Real-time fluorescence tracking of dynamic transgene variegation in stem cells. Mol. Ther. 15, 810-817. (Pubitemid 46432002)
81. Recillas-Targa, F., Pikaart, M.J., Burgess-Beusse, B., et al. (2002). Position-effect protection and enhancer blocking by the chicken beta-globin insulator are separable activities. Proc. Natl. Acad. Sci. U. S. A. 99, 6883-6888. (Pubitemid 34526227)
82. Rhode, B.W., Emerman, M., and Temin, H.M. (1987). Instability of large direct repeats in retrovirus vectors. J. Virol. 61, 925-927. (Pubitemid 17040225)
83. Rivella, S., Callegari, J.A., May, C., et al. (2000). The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites. J. Virol. 74, 4679-4687. (Pubitemid 30237894)
84. Robert-Richard, E., Richard, E., Malik, P., et al. (2007). Murine retroviral but not human cellular promoters induce in vivo erythroid-specific deregulation that can be partially prevented by insulators. Mol. Ther. 15, 173-182. (Pubitemid 46043663)
85. Rubio, E.D., Reiss, D.J., Welcsh, P.L., et al. (2008). CTCF physically links cohesin to chromatin. Proc. Natl. Acad. Sci. U. S. A. 105, 8309-8314. (Pubitemid 351904752)
86. Ryu, B.Y., Evans-Galea, M.V., Gray, J.T., et al. (2008). An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation. Blood 111, 1866-1875. (Pubitemid 351451495)
87. Ryu, B.Y., Persons, D.A., Evans-Galea, M.V., et al. (2007). A chromatin insulator blocks interactions between globin regulatory elements and cellular promoters in erythroid cells. Blood Cells Mol. Dis. 39, 221-228. (Pubitemid 47484460)
88. Savitskaya, E., Melnikova, L., Kostuchenko, M., et al. (2006). Study of long-distance functional interactions between Su(Hw) insulators that can regulate enhancer-promoter communication in Drosophila melanogaster. Mol. Cell. Biol. 26, 754-761. (Pubitemid 43146473)
89. Schambach, A., Galla, M., Maetzig, T., et al. (2007). Improving transcriptional termination of self-inactivating gamma-retro-viral and lentiviral vectors. Mol. Ther. 15, 1167-1173. (Pubitemid 46813620)
90. Shou, Y., Ma, Z., Lu, T., and Sorrentino, B.P. (2006). Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy. Proc. Natl. Acad. Sci. U. S. A. 103, 11730-11735. (Pubitemid 44182519)
91. Steinwaerder, D.S., and Lieber, A. (2000). Insulation from viral transcriptional regulatory elements improves inducible trans-gene expression from adenovirus vectors in vitro and in vivo. Gene Ther. 7, 556-567. (Pubitemid 30175558)
92. Tajima, S., Shinohara, K., Fukumoto, M., et al. (2006). Ars insulator identified in sea urchin possesses an activity to ensure the transgene expression in mouse cells. J. Biochem. 139, 705-714. (Pubitemid 43973917)
93. 0LTR. Mol. Ther. 17, 1527-1536.
94. Van Meerten, T., Classen, M.J., Hagenbeek, A., and Ebeling, S.B. (2006). The CD20/alphaCD20 "suicide" system: novel vectors with improved safety and expression profiles and efficient elimination of CD20-transgenic T cells. Gene Ther. 13, 789-797.
95. Vieyra, D.S., and Goodell, M.A. (2007). Pluripotentiality and conditional transgene regulation in human embryonic stem cells expressing insulated tetracycline-ON transactivator. Stem Cells 25, 2559-2566. (Pubitemid 47582748)
96. Walisko, O., Schorn, S., Rolfs, F., et al. (2008). Transcriptional activities of the Sleeping Beauty transposon and shielding its genetic cargo with insulators. Mol. Ther. 16, 359-369. (Pubitemid 351168045)
97. West, A.G., Gaszner, M., and Felsenfeld, G. (2002). Insulators: many functions, many mechanisms. Genes Dev. 16, 271-288. (Pubitemid 34111407)
98. West, A.G., Huang, S., Gaszner, M., et al. (2004). Recruitment of histone modifications by USF proteins at a vertebrate barrier element. Mol. Cell 16, 453-463. (Pubitemid 39504798)
99. Yannaki, E., Tubb, J., Aker, M., et al. (2002). Topological constraints governing the use of the chicken HS4 chromatin insulator in oncoretrovirus vectors. Mol. Ther. 5, 589-598. (Pubitemid 34546089)
100. Yao, S., Osborne, C.S., Bharadwaj, R.R., et al. (2003). Retrovirus silencer blocking by the cHS4 insulator is CTCF independent. Nucleic Acids Res. 31, 5317-5323. (Pubitemid 37441899)
101. Yao, S., Sukonnik, T., Kean, T., et al. (2004). Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications. Mol. Ther. 10, 27-36. (Pubitemid 38878146)
102. Ye, X., Liang, M., Meng, X., et al. (2003). Insulation from viral transcriptional regulatory elements enables improvement to hepatoma-specific gene expression from adenovirus vectors. Biochem. Biophys. Res. Commun. 307, 759-764. (Pubitemid 36871636)
103. 0-HS4 chicken beta-globin insulator is a CTCF-dependent nuclear matrix-associated element. Proc. Natl. Acad. Sci. U. S. A. 101, 8620-8624. (Pubitemid 38745820)
104. 0 readthrough of oncoretrovirus and lentivirus: implications for vector safety and efficacy. J. Virol. 76, 7209-7219.
105. Zhang, F., Thornhill, S.I., Howe, S.J., et al. (2007). Lentiviral vectors containing an enhancer-less ubiquitously-acting chro-matin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells. Blood 110, 1448-1457. (Pubitemid 47443959)
106. Zhao, H., and Dean, A. (2006). An insulator blocks spreading of histone acetylation and interferes with RNA polymerase II transfer between an enhancer and gene. Nucleic Acids Res. 32, 4903-4919.
107. Zhou, S., Mody, D., Deravin, S.S., et al. (2010). A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells. Blood 116, 900-908.
108. Zychlinski, D., Schambach, A., Modlich, U., et al. (2008). Physiological promoters reduce the genotoxic risk of integrating gene vectors. Mol. Ther. 16, 718-725. (Pubitemid 351426173)